Effectiveness and cost-effectiveness of Imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: A systematic review and economic analysis

Kim Marie Dalziel, Ali Round, Ken Stein, Ruth Garside, A Price

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Pages (from-to)3 - 67
Number of pages65
JournalHealth Technology Assessment
Issue number28
Publication statusPublished - 2004

Cite this